Vivos Therapeutics, Inc.
VVOS
$2.55
-$0.0199-0.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 538.77% | 75.11% | -62.94% | -53.31% | -85.30% |
| Total Receivables | 99.12% | 20.80% | 63.55% | -55.80% | -73.67% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -17.56% | -48.37% | -64.71% | -57.46% | -63.66% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 272.75% | 46.99% | -58.56% | -54.63% | -79.54% |
|
|
|||||
| Total Current Assets | 272.75% | 46.99% | -58.56% | -54.63% | -79.54% |
| Net Property, Plant & Equipment | -6.38% | -6.96% | -3.01% | -1.63% | -8.18% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -11.55% | -11.24% | -10.92% | 39.07% | 38.78% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.10% | -10.39% | 0.00% | -17.91% | -17.47% |
| Total Assets | 48.75% | 15.22% | -30.97% | -21.79% | -43.93% |
|
|
|||||
| Total Accounts Payable | -29.65% | 53.06% | 67.16% | 52.02% | 137.27% |
| Total Accrued Expenses | 6.87% | 12.11% | 27.11% | 22.07% | -11.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.43% | 8.28% | 11.55% | 13.13% | 3.14% |
| Total Finance Division Other Current Liabilities | -53.58% | -58.76% | -36.16% | -23.93% | 20.85% |
| Total Other Current Liabilities | -53.58% | -58.76% | -36.16% | -23.93% | 20.85% |
| Total Current Liabilities | -28.48% | -21.29% | 1.19% | 6.99% | 20.17% |
|
|
|||||
| Total Current Liabilities | -28.48% | -21.29% | 1.19% | 6.99% | 20.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -29.56% | -27.44% | -25.66% | -23.72% | -31.53% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.25% | 9.24% | 601.20% | 1,247.32% | 711.11% |
| Total Liabilities | -25.21% | -18.45% | 11.03% | 15.70% | 20.20% |
|
|
|||||
| Common Stock & APIC | 22.72% | 18.34% | 10.47% | 10.91% | 6.73% |
| Retained Earnings | -14.15% | -13.89% | -19.27% | -17.09% | -21.00% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 16,563.04% | 201.38% | -91.68% | -91.44% | -99.53% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16,563.04% | 201.38% | -91.68% | -91.44% | -99.53% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16,563.04% | 201.38% | -91.68% | -91.44% | -99.53% |
|
|
|||||
